Intense Multifactorial Treatment for Type 2 Diabetes Shown to be Cost Effective

Orlando, Florida - When patients with type 2 diabetes (T2D) receive intensified, multifactorial treatment combining lifestyle modification and pharmacological therapy for modifiable risk factors, there is no significant increase in medical costs, compared to patients who receive conventional, multifactorial treatment, according to the study, “A Cost Analysis of Intensified vs. Conventional Multifactorial Therapy of Patients with Type 2 Diabetes—The Steno 2 Study,” presented at the American Diabetes Association’s® (ADA’s) 78th Scientific Sessions® at the Orange County Convention Center.

Resuscitation science and technology leaders call for paradigm shift to CPR

Dallas, Texas - The American Heart Association, the world’s leading voluntary health organization dedicated to building healthier lives, free of cardiovascular diseases and stroke, and Laerdal Medical, a major, global medical equipment and medical training products manufacturer based in Stavanger, Norway, are furthering their decades-long alliance to deliver a new standard of resuscitation quality and patient care centered on CPR competence.

Dr. Steve Goldman Appointed to C. Leonard Pfeiffer Chair of Cardiovascular Medicine at UA Sarver Heart Center

Tucson, Arizona - Steve Goldman, MD, professor of medicine in the Division of Cardiology at the University of Arizona College of Medicine – Tucson, was named to fill the prestigious C. Leonard Pfeiffer Chair in Cardiovascular Medicine at the UA Sarver Heart Center.

NIH-funded researchers present preliminary clinical trial results suggesting aggressive blood pressure control may lower risk of cognitive impairment

Washington, DC - Preliminary findings from a large clinical trial, the Systolic Blood Pressure Intervention Trial (SPRINT) Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study will be presented at the Alzheimer’s Association International Conference in Chicago on July 25. The findings suggest that intensive lowering of blood pressure may reduce the risk of mild cognitive impairment (MCI) and the combined risk of MCI and dementia, but not dementia alone. The SPRINT MIND study was funded by the National Institutes of Health.

Colon Cancer Expert Joins UA/Banner as Chief of Gastroenterology

Tucson, Arizona - Juanita L. Merchant, MD, PhD, a renowned physician-scientist who has made paradigm-shifting contributions to understanding the gastric response to chronic inflammation and colon cancer, joins the University of Arizona College of Medicine – Tucson faculty this month as the new chief of the Division of Gastroenterology and Hepatology in the Department of Medicine.